Novavax (NVAX)
(Delayed Data from NSDQ)
$4.93 USD
+0.22 (4.67%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.90 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVAX 4.93 +0.22(4.67%)
Will NVAX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVAX
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
What's in the Cards for Amgen (AMGN) This Earnings Season?
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Other News for NVAX
Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more
Novavax Inc. stock outperforms competitors on strong trading day
Russell 2000 Q1 2024 Earnings Preview: Sharp Downward Revisions Precede Earnings Season
Novavax Inc. stock rises Thursday, still underperforms market
Novavax Inc. stock outperforms competitors on strong trading day